Article Versions Notes

Iglesias J, Vassallo AV, Liesenfeld O, Levine JS, Patel VV, Sullivan JB, Cavanaugh JB, Elbaga Y, Sweeney TE. A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial. Journal of Personalized Medicine. 2021; 11(1):9. https://doi.org/10.3390/jpm11010009

Iglesias, Jose, Andrew V. Vassallo, Oliver Liesenfeld, Jerrold S. Levine, Vishal V. Patel, Jesse B. Sullivan, Joseph B. Cavanaugh, Yasmine Elbaga, and Timothy E. Sweeney. 2021. "A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial" Journal of Personalized Medicine 11, no. 1: 9. https://doi.org/10.3390/jpm11010009

Iglesias, J., Vassallo, A. V., Liesenfeld, O., Levine, J. S., Patel, V. V., Sullivan, J. B., Cavanaugh, J. B., Elbaga, Y., & Sweeney, T. E. (2021). A 33-mRNA Classifier Is Able to Produce Inflammopathic, Adaptive, and Coagulopathic Endotypes with Prognostic Significance: The Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis (ORANGES) Trial. Journal of Personalized Medicine, 11(1), 9. https://doi.org/10.3390/jpm11010009